BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/9/2021 9:07:56 AM | Browse: 876 | Download: 1884
 |
Received |
|
2021-02-01 12:32 |
|
Peer-Review Started |
|
2021-02-01 12:36 |
|
First Decision by Editorial Office Director |
|
2021-02-27 05:57 |
|
Return for Revision |
|
2021-02-27 05:57 |
|
Revised |
|
2021-03-13 13:31 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2021-03-19 11:21 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2021-03-19 14:44 |
|
Articles in Press |
|
2021-03-19 14:44 |
|
Edit the Manuscript by Language Editor |
|
2021-03-23 22:10 |
|
Typeset the Manuscript |
|
2021-03-30 14:23 |
|
Publish the Manuscript Online |
|
2021-04-09 09:07 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Minireviews |
| Article Title |
COVID-19 and gastrointestinal tract: Source of infection or merely target of the inflammatory process following SARS-CoV-2 infection?
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Jacopo Troisi, Giorgia Venutolo, Meritxell Pujolassos Tanyà, Matteo Delli Carri, Annamaria Landolfi and Alessio Fasano |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Jacopo Troisi, MBBS, MSc, Additional Professor, Professor, Metabolomics Section, Theoreo srl - Spin-off Company of the University of Salerno, Via degli Ulivi, 3, Montecorvino Pugliano 84090, SA, Italy. troisi@theoreosrl.com |
| Key Words |
COVID-19; SARS-CoV-2; Gastrointestinal symptoms; Gut microbiome; Dysbiosis; Zonulin; Fecal-oral transmission |
| Core Tip |
Coronavirus disease 2019 patients may suffer from gastrointestinal symptoms, which have been associated to gastrointestinal dysbiosis. Even though the exact role of gut microbiome perturbation (as a cause or a consequence of the disease) is still to be elucidated, pharmacological interventions aimed at containing intestinal permeability may be of support for coronavirus disease 2019 patients. |
| Publish Date |
2021-04-09 09:07 |
| Citation |
Troisi J, Venutolo G, Pujolassos Tanyà M, Delli Carri M, Landolfi A, Fasano A. COVID-19 and gastrointestinal tract: Source of infection or merely target of the inflammatory process following SARS-CoV-2 infection? World J Gastroenterol 2021; 27(14): 1406-1418
|
| URL |
https://www.wjgnet.com/1007-9327/full/v27/i14/1406.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v27.i14.1406 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
